Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-30 @ 8:49 PM
Study NCT ID:
NCT03661632
Status:
COMPLETED
Last Update Posted:
2021-11-08
First Post:
2018-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-29
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-30
First Submit QC Date:
None
Study First Post Date:
2018-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-31
Last Update Post Date:
2021-11-08
Last Update Post Date Type:
ACTUAL